![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aviva Plc | LSE:AV. | London | Ordinary Share | GB00BPQY8M80 | ORD 32 17/19P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.10 | -0.23% | 476.50 | 476.90 | 477.20 | 481.30 | 476.70 | 478.40 | 4,067,017 | 16:35:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Insurance Carriers, Nec | 41.43B | 1.09B | 0.3961 | 12.04 | 13.07B |
Date | Subject | Author | Discuss |
---|---|---|---|
31/7/2020 08:26 | All of the above and more imho. I would suggest that they are overpaid parasites. | imagining | |
30/7/2020 23:59 | Either Our great legal brains are very very slow thinkers, or they are lackadaisical ,lazy and lack a sense of urgency. Or just all of the above. Would not last ten minutes in the real world of private enterprise . | ![]() dbadvn | |
30/7/2020 20:46 | Bit about the court case Following the closing submissions, the presiding judges, Lord Justice Flaux and Mr Justice Butcher, said they would aim to deliver a draft judgment by mid-September. Based on FCA estimates, their findings will affect as many as 370,000 policyholders — and each successful claim could potentially run to tens of thousands of pounds. Going to be some time. | ![]() dr biotech | |
30/7/2020 18:00 | I think this is a good share, but its just too expensive atm, my vision is public toilet with cheap toilet paper, time to punch through to new lows soon. | hhhold2 | |
30/7/2020 16:43 | ... which direction for the DOW? | ![]() eurofox | |
30/7/2020 16:43 | ..bounce off 6000? | ![]() eurofox | |
30/7/2020 16:04 | DOW will drop again after we close. | hhhold2 | |
30/7/2020 15:51 | ... no patience | ![]() eurofox | |
30/7/2020 15:43 | I first thought that 20 years ago... | ![]() uppompeii | |
30/7/2020 15:25 | I regret buying this, and continuing to add when it dropped. Any progress seems to just get wiped, just when I start to think its not all bad! | dmdmdmdm1 | |
30/7/2020 15:09 | ...and again at 262 in ISA | ![]() eurofox | |
30/7/2020 14:19 | I was recently in a potential IT growth company with a T/O of £130 million, Market cap. 944 million, P/E ratio of 79,organic growth 2%, but earnings growth through acquisitions, and its share price is up today. I had got a bit concerned and sold, but this is a strange market, and prefer what I regard as a relatively safe sector, like some Pharma companies. I saw the light on IAG (BA) at the outset of the virus in China and exited at 640p, because at the time I saw the global impact the China initial outbreak could have on global activity/Travel etc. One just has to position oneself for hopefully better times globally next year. With RSA committing to reverting to dividends up to their F/Y , I assume that AV. will adopt a similar approach and holders will have already anticipated this, maybe? Guess that would produce/save about £1.2 billion into reserves/capital, and maybe the market will consider such action as prudent, and positive for a return to better times ahead. Agree that all our comments here on the bb are just personal views and that the market will wander in all directions until it sees a light in the tunnel.Interesting that my other half has just added some LGEN after their 7% fall today...their CEO is a tough cookie and will do whatever he feels best with their figures out the day before AV. next week Good luck/wishes to all.... | ![]() cyberian | |
30/7/2020 12:12 | Just need a few more days like this and I look down the sofa & think about get just small amount of these. Still on the pricy side atm. | hhhold2 | |
30/7/2020 11:59 | L&G taking a real hammering | ![]() eurofox | |
30/7/2020 11:58 | Absolute bloodbath today if invested in AV and Lloy like i am ? | ![]() wadders5 | |
30/7/2020 11:40 | I strongly suspect that any hope for a 3rd Party uninvited Corporate solution to the Senior Management woes of AV has long gone... As it hasn't happened by now, it isn't going to happen? However, athough I have no proof, I believe that there is a substantial push by Institutional shareholders for meaningful change at AV. This started with their profound disappointment with Tulloch's 'Review' last Autumn. I don't belive that ABs appointment to the the Board in early 2020 and subseqent move to CEO was any accident. Also, prior to his appointment as Chairman, it was made crystal clear to GC that substantial change was needed GC and AB have only 6 months to set out their stall. Begining with the statement accompanying the Interim Results next week and then the preliminary abnnouncement of the Full Year Results in December which should also include a definitive Dividend announcement If they fail...??? | ![]() 1robbob | |
30/7/2020 11:02 | Very poor management has left AV. in this position sadly this is not the only company in the UK with bad management I believe that even this latest offering we have as CEO will be more of the same . The only way forward is to break AV. up and sell all as present management are incapable of improving the company. God forbid they go on an acquisition spree all value will be lost here, if you look at the Friends Provident buy as the latest example of value destruction. | ![]() wskill | |
30/7/2020 10:52 | The price action does not bode well for next weeks update. | ![]() mountpleasant | |
30/7/2020 10:12 | i agree on quantum WBA but its such a curious collection of businesses that i do wonder why an industry buyer would see value in it. I'm also not sure an industry buyer would buy it to break it apart. for eg another to add to your list might be Canada life who have European aspirations above their current businesses in annuity and protection predominantly in the UK. but i doubt the Canadian business is helpful in that analysis. i had wondered for a while whether a PE or activist might get interested. however the PRA is so unfriendly to PE in insurance i find it hard to believe anyone would take it on. in my own experience, taking out an insurer is a licence for the PRA to revisit all the capital assumptions which adds huge uncertainty. activist might be more likely eg elliot or third point but I'm not holding out for that as a realistic option. reinstating divi, high 3s and sub 8% yield, and that will probably do for me. | ![]() cjac39 | |
30/7/2020 10:07 | .. hopefully to gap at around 260 will get filled | ![]() eurofox | |
30/7/2020 10:03 | .. and again in SIPP at 266 | ![]() eurofox | |
30/7/2020 10:01 | Disagree that Aviva is immune to takeover, although I would agree there are few who could take it out. Obviously the big 3 (Allianz/Axa/Zurich) could do so but all have other priorities. The most likely would probably be either Generali (except they are currently looking at a US buy and would need to increase their stated acquisition appetite - but they could finance it), or a left field option (such as Berkshire Hathaway with a view to break up or even a vulture approach for the same purpose). A £10bn (or maybe up to £15bn for a successful bid) is well within the financial capabilities of 5-10 insurers globally and many other potential bidders. But do I see it happening? Probably not. | ![]() wba1 | |
30/7/2020 09:52 | eurofox...added as well...hope not a curse, but see some sense at these levels and so much more uncertainty in other sectors. The Hastings move is quite interesting and helps confidence in those who see value. I am more optimistic that the action being taken globally on the virus will provide clear solution and remedy, and we can all revert/plan for a better 2021. | ![]() cyberian | |
30/7/2020 09:47 | Looking at the markets we seems to be heading into a potential W shaped recovery, well one hopes of that. | smurfy2001 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions